Shobaki et al. utilized a mouse model with xenografts of human renal cancer and lipid nanoparticles to specifically shuttle siRNA targeting STAT3 and hypoxia-inducible factor 1-alpha (HIF-1α) to TAMs. The gene discussed is HIF1A; the disease is renal carcinoma.